This article is brought to you by the new Higher Learning LV Core Cannabis course. Learn the 25 most important cannabinoids and eight most common terpenes for an affordable enrollment fee of only $240.
Cannabis for Inflammatory Bowel Diseases. A 2020 study entitled "Role of Cannabis in Inflammatory Bowel Diseases" that was published in the peer-reviewed journal Annals of Gastroenterology investigated the potential efficacy of medical cannabis for inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.
"Some observational and small placebo-controlled studies have been conducted to examine the effects of cannabis on IBD, and some of these studies have shown promising results," noted the study. "Though cannabis can cause many harmful effects, its medicinal properties cannot be denied," reported the scientists.
Cannabis for Inflammatory Bowel Diseases Conclusions
Cannabis for Inflammatory Bowel Diseases. The research concluded the following:
"In this review, we have tried to comprehensively discuss the applicability of cannabis in IBD. Although some promising results in relieving IBD-related symptoms were found in a few studies, cannabis for medicinal use in IBD is still questionable, given the limited high-quality clinical evidence and the side effects.
"Although some promising results in relieving IBD-related symptoms were found in a few studies, cannabis for medicinal use in IBD is still questionable."
"Researchers are asking for a reclassification of cannabis from Schedule I drug so that they can design safer cannabinoid derivatives for use in clinical trials. Further high-quality randomized clinical trials with larger sample size are warranted to determine the appropriate dose, route of administration, and side-effects of cannabis before it can be accepted as a possible therapeutic agent for IBD."
View the original study.
Did you enjoy Cannabis for Inflammatory Bowel Diseases? Are you a cannabis industry professional? Check out Higher Learning LV's Deep Dive Subscription that features dozens of long-form articles based on the latest peer-reviewed scientific research. Priced to accommodate personal and enterprise training budgets.